Fundraising FoxEquilibre Biopharmaceuticals
New York, US · Founded 2020 · Delaware corporation · 1 known investors
Find your way into Equilibre Biopharmaceuticals
Sign up to see every warm intro you have to Equilibre Biopharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Equilibre Biopharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Equilibre Biopharmaceuticals was founded in 2020 by Sam Waksal.
SW
Sam WaksalFounder
SG
Steven GordonNamed on SEC filing
FM
Francois MaisonrougeNamed on SEC filing
JM
Joel MarcusNamed on SEC filing
DF
David FriedmanNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$47.7M disclosed across 3 rounds · 2020–2022
▶$6MraisedDec 2022 · 13 investors · PharmaceuticalsRule 506(b)
▶$6MraisedDec 2022 · 13 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Philip A. BarachExecutive Officer, Director
- Christopher ThornExecutive Officer
- Christina RamirezDirector
- Peter M. SimonDirector
- David FriedmanDirector
- Steven N. GordonExecutive Officer, Director
- Francois MaisonrougeDirector
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$15.9MraisedJan 2022 · 14 investors · PharmaceuticalsRule 506(b)
▶$15.9MraisedJan 2022 · 14 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Peter SimonDirector
- David FriedmanDirector
- Francois MaisonrougeDirector
- Philip BarachDirector
- Steven GordonExecutive Officer, Director
- Samuel WaksalExecutive Officer, Director
- Joel MarcusDirector
- Offering amount
- $25M
- Amount sold
- $15.9M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$25.8MraisedNov 2020 · 14 investors · PharmaceuticalsRule 506(b)
▶$25.8MraisedNov 2020 · 14 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Steven GordonExecutive Officer
- Sam WaksalExecutive Officer
- Francois MaisonrougeDirector
- Joel MarcusDirector
- David FriedmanDirector
- Offering amount
- $35.8M
- Amount sold
- $25.8M
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Equilibre Biopharmaceuticals?
- Equilibre Biopharmaceuticals was founded by Sam Waksal in 2020.
- Who are Equilibre Biopharmaceuticals's investors?
- Equilibre Biopharmaceuticals's investors include Third Point Ventures.
- How much funding has Equilibre Biopharmaceuticals raised?
- Equilibre Biopharmaceuticals has disclosed $47.7M raised across 3 rounds.
- Where is Equilibre Biopharmaceuticals headquartered?
- Equilibre Biopharmaceuticals is headquartered in New York, US.